Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors
申请人:Incyte Corporation
公开号:US10000507B2
公开(公告)日:2018-06-19
The present disclosure describes furo- and thieno-pyridine carboxamide compounds, as well as their compositions and methods of use. The compounds inhibit the activity of the Pim kinases, and are useful in the treatment of diseases related to the activity of Pim kinases including, e.g., cancer and other diseases.
[EN] FURO- AND THIENO-PYRIDINE CARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS<br/>[FR] COMPOSÉS DE FURO- ET THIÉNO-PYRIDINECARBOXAMIDE UTILES EN TANT QU'INHIBITEURS DE KINASES PIM
申请人:INCYTE CORP
公开号:WO2015027124A1
公开(公告)日:2015-02-26
The present disclosure describes furo-and thieno-pyridine carboxamide compounds of Formula (I) or a pharmaceutically acceptable salt thereof, wherein: X is S or 0; A5 is N or C-R5. CyA is a 5 to 6 membered monocyclic heteroaryl group, wherein the ring atoms of the heteroaryl group forming CyA consist of carbon atoms and 1, 2, or 3 heteroatoms selected from N, 0 and S, and wherein the 5 to 6 membered monocyclic heteroaryl group forming CyA is unsubstituted or substituted with 1, 2, or 3 RA; CyB is C6-10aryl, C3-7cycloalkyl, 5-10 membered heteroaryl or 4-10 membered heterocycloalkyl wherein the ring atoms of the ring atoms of the heteroaryl or heterocycloalkyl forming CyB consist of carbon atoms and 1, 2 or 3 heteroatoms selected from 0, N and S, and wherein each of said C6-10aryl, C3-7cycloalkyl, 5-10 membered heteroaryl or 4-10 membered heterocycloalkyl forming CyB is unsubstituted or substituted with 1, 2, 3, 4 or 5 RB; R2 is H, halogen or NH2; and R5, R6 and R7 are as defined in claim 1; The compounds inhibit the activity of the Pim kinases, and are useful in the treatment of diseases related to the activity of Pim kinases including, e.g., cancer and other diseases.